0 Items

Right now, the focus of is to make sure all readers are as UPDATED as possible on the Covid-19 pandemic.

Download our EXCLUSIVE report immediately at

We’re approaching ELECTION TIME and our estimates are that MEDIA BRAINWASHING on both ends of the spectrum will become overwhelmingly AGGRESSIVE. I truly expect to see some of the wildest RATINGS NUMBERS to ever print!

The world is about to be GLUED TO SCREENS.

There’s so much GOING ON across the planet that it’s getting hard to just TAKE A MOMENT to breathe.

We have Obamagate, Covid-19 re-openings, the Minneapolis police SCANDAL – which infuriates me, I loathe police brutality and internal cover-ups – politicizing of Covid-19 origins and over-counting, Hong Kong losing its liberty and the list is LONG AND OMINOUS.

In all of this, we also must remember that just over 40 MILLION Americans are claiming unemployment benefits and that the Federal Reserve’s LENDING FACILITIES have barely been TAPPED yet.


In light of this, the market’s INCREDIBLE P/E LEVELS are predicting 0% returns, in real terms, on a 10-yr basis.

In the March Lows, we published THIS WATCH LIST – download HERE!

It OFFERED US a tremendous inside look into some of the highest-conviction opportunities that my partners and I were positioning in, including LIMIT ORDERS.

  1. American Express: Because of the PANIC and the lockdown, shares of AXP fell dramatically.

Our limit order was at $78; notice that we HAD CALLED the exact bottom!

In two weeks, this position is up 25%. It’s up to EACH ONE to determine whether to lock short-term gains, REPRESENTING 3 YEARS’ worth of average AXP returns (this company returns 8%/annum, historically) or to keep holding.

Regardless, this is a PERFECT TRADE, entered at the exact MATHEMATICAL BOTTOM!

On our watch list, this wasn’t the only PERFECTLY-TIMED order…

  1. VF Corp: Our limit order here MARKED THE BOTTOM as well!

Since hitting $52/share, the stock is up 19% in two weeks.

93% Of Investors Generate Annual Returns, Which Barely Beat Inflation.

Wealth Education and Investment Principles Are Hidden From Public Database On Purpose!

Build The Knowledge Base To Set Yourself Up For A Wealthy Retirement and Leverage The Relationships We Are Forming With Proven Small-Cap Management Teams To Hit Grand-Slams!

I expect volatility and a LENGTHY RECOVERY from retail clothing manufacturers, so I’m considering LOCKING GAINS on this one, personally.

Thirdly, let’s discuss EGF Theramed Health (CAD: TMED & US: EVAHF):

Our OFFICIAL PROFILE price is CAD$1.22. Since then, we’ve already seen a HIGH OF CAD$1.90, so the opportunity to LOCK GAINS of at least 21.7% and UPWARDS of 55.6%, was PRESENT for each this week.

Personally, I’m not a day-trader. I am also aware that a company as young as this one, which DOESN’T GENERATE REVENUE yet, is impossible to truly evaluate. We can ONLY SPECULATE as to:

  1. How valuable the breakthrough processing technology is, which allows psilocybin to be grown in 3 days, instead of 70 days. Per the company’s news, they’ve ALREADY RETAINED a law firm to help file a patent on this technology.
  2. How long it would take the British Virgin Islands facility to be developed, constructed and operating properly.

Of course, per the company’s LATEST NEWS, we can ONLY SPECULATE as to what the new CEO’s next move will be, as he indicated that the company is HUNTING FOR a new asset.

Personally, I would love to see them enter a field that CAN GENERATE REVENUE, which will dramatically de-risk the whole operation; time will tell…

My point is that this is a HIGH-RISK TRADE, as were the early cannabis operators back in their day, but holding them resulted in life-changing profits.

In the world of VENTURE INVESTING, the stakes are high and the TIMELINE UNKNOWN.

Our BIGGEST CATALYST is further de-criminalization of substances such as Ketamine, Psilocybin, MDMA and others for medicinal uses, all of which the public has been BRAINWASHED BY BIG-GOVERNMENT to fear – yet, administered in a scientific way, these offer BREAKTHROUGH RESULTS, documented and testified by the patients themselves.

Always, always, always have a game plan ready for both EXCEPTIONAL SUCCESS, if the industry begins to enjoy legislative tailwind, OR for DETRIMENTAL BACKLASH and headwinds.

Keep an eye out for both; one has to be responsible for his decisions and actions IN HIGH-STAKES venture investing.

EXCLUSIVE REPORTS, Featured In This Article and in Others, Which Are Considered ESSENTIAL READING:
1. Gold Investing – DOWNLOAD HERE!
2. Trump’s War with Mainstream Media – DOWNLOAD HERE!
3. Covid-19 Round2 Sell-Off Playbook – DOWNLOAD HERE!
4. Why The Dollar Is Dead – DOWNLOAD HERE!

Best Regards,

James Davis

Governments Have Amassed ungodly Debt Piles and Have Promised Retirees Unreasonable Amounts of Entitlements, Not In Line with Income Tax Collections. The House of Cards Is Set To Be Worse than 2008! Rising Interest Rates Can Topple The Fiat Monetary Structure, Leaving Investors with Less Than Half of Their Equity Intact!

Protect Yourself Now, By Building A Fully-Hedged Financial Fortress!

We are not brokers, investment or financial advisers, and you should not rely on the information herein as investment advice. We are a marketing company. If you are seeking personal investment advice, please contact a qualified and registered broker, investment adviser or financial adviser. You should not make any investment decisions based on our communications. You should know that Gold Standard Media LLC, owned by the same parties as Future Money Trends LLC, has been compensated three hundred thousand dollars, directly by the company, for a forty five day public awareness campaign. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT recommendations. The securities issued by the companies we profile should be considered high risk and, if you do invest, you may lose your entire investment. Please do your own research before investing, including reading the companies’ SEC filings, press releases, and risk disclosures. Information contained in this profile was provided by the company, extracted from SEC filings, company websites, and other publicly available sources. We believe the sources and information are accurate and reliable but we cannot guarantee it. 

Please read our full disclaimer at